Astragalus and kidney function
What 2 graded rows on astragalus agree on for kidney function, and where they differ. Counted side by side, never averaged.
Consensus finder Rows from the Astragalus page, reviewed Oct 21, 2026 How it decides
What the rows agree on
Each block and row is one graded row from the Astragalus page, with its PubMed record.
Your question
Astragalus and kidney function
2 rows · 354 peopleThey agree: both rows found an improvement.
- CGrade C× 2
- Rows
- 2
- Trials
- 2
- At least: a review without a trial count
- People
- 354
- Pooled reviews may count some twice
What the rows share
From the rowsThe best-graded row, grade C, is a meta-analysis of 236 people (2019) and found an improvement.
The rows run from 118 to 236 people, published from 2019 to 2024: 1 pooled review and 1 single study.
The rows
2 improved- CGrade CAlbuminuria in diabetic kidney disease (oral preparations) · Improved
Meta-analysis · n 236 · 2019 · People with diabetic kidney disease in 4 RCTs of oral astragalus added to conventional therapy (China)
Varied by trial · Short term
Albuminuria fell more than with conventional therapy alone (SMD -1.27, 95% CI -1.82 to -0.73).
- CGrade CKidney function decline in diabetic kidney disease · Improved
RCT · n 118 · 2024 · Adults with type 2 diabetes, stage 2-3 chronic kidney disease and macroalbuminuria (Hong Kong)
15 g raw herb equivalent per day · 48 weeks
eGFR declined 4.6 mL/min/1.73 m2 per year more slowly than with standard care alone (95% CI 1.5-7.6); albuminuria slope did not differ; endpoint systolic blood pressure was 7.9 mm Hg lower.